Neuraxpharm Strikes Long-Acting Injectables Deal With Pharmathen

The Agreement Grants Neuraxpharm Exclusive European Rights To The Therapies

 
• By Adam Zamecnik
  
The IGBA has kicked off its latest Global Biosimilars Week (Shutterstock)

More from Deals

More from Generics Bulletin